Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma

PURPOSE: We retrospectively analyzed the risk of recurrence and conditional Disease-Free Survival (cDFS) in 63 patients with complete remission during treatment with tirosin kinase inhibitor (TKI), alone or with local treatment in metastatic renal cell carcinoma. RESULTS: 37% patients achieve CR wit...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncotarget
Главные авторы: Santini, Daniele, Santoni, Matteo, Conti, Alessandro, Procopio, Giuseppe, Verzoni, Elena, Galli, Luca, di Lorenzo, Giuseppe, De Giorgi, Ugo, De Lisi, Delia, Nicodemo, Maurizio, Maruzzo, Marco, Massari, Francesco, Buti, Sebastiano, Altobelli, Emanuela, Biasco, Elisa, Ricotta, Riccardo, Porta, Camillo, Vincenzi, Bruno, Papalia, Rocco, Marchetti, Paolo, Burattini, Luciano, Berardi, Rossana, Muto, Giovanni, Montironi, Rodolfo, Cascinu, Stefano, Tonini, Giuseppe
Формат: Artigo
Язык:Inglês
Опубликовано: Impact Journals LLC 2016
Предметы:
Clinical Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5078103/
https://ncbi.nlm.nih.gov/pubmed/27027342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8302
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы